Clinical Trial Update: Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of two topical MOB015 regimens in adults with distal subungual onychomycosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• MOB015

Snippet

Sponsor: Moberg Pharma AB | Conditions: Onychomycosis | Phase 2 | Status: COMPLETED